Yahoo Finance

ZEPBOUND™ KWIKPEN® (TIRZEPATIDE INJECTION), THE FIRST AND ONLY DUAL RECEPTOR AGONIST FOR THE TREATMENT OF OBESITY, NOW APPROVED AND AVAILABLE IN CANADA

Adults taking tirzepatide injection in a clinical trial lost on average 21.8 kg (48 lbs.) at the highest dose TORONTO, July 9, 2025 /CNW/ - Eli Lilly Canada is pleased to announce that ZEPBOUND™ ...
Forbes

Liraglutide vs. Tirzepatide For Weight Loss: What’s The Difference?

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...

GLP-1 injections recalled across the US over sterility concerns: How contaminated vials and dosing errors can put patients at risk

A comprehensive recall of compounded tirzepatide injections has been announced due to sterility concerns that have raised ...
Hosted on MSN

Can B12 enhance the weight loss benefits of tirzepatide?

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Tirzepatide with B12 is sometimes combined as a weekly injection for weight loss. Vitamin B12 supplementation may reduce fatigue ...